CD&R, a private investment firm, faces significant challenges in achieving its goal of 20% returns with Sanofi, a French multinational pharmaceutical company. According to recent reports, CD&R is working on a potential deal to acquire a majority stake in Sanofi's animal health division, which could be valued at around $10 billion. The acquisition would mark CD&R's first major move into the healthcare sector.

Source: https://www.bloomberg.com/opinion/articles/2024-10-23/cd-r-faces-tough-road-to-20-returns-with-sanofi